Ann: Cynata Successfully Completes Capital Raising, page-44

Yes. No dilution. Big upfront cash payment. One drug, one disease and one country! AUD$22m and 50/50 JV.

If I knew how much costs would be for production I would have a better idea of what lies ahead. All I know on that is the product is potentially worth billions we would all agree I'm sure. If they can go the distance it will be worth the effort to get 50%. I don't think our JV partner will sting us too much either on production costs as they will be the ones producing it!

Happy for any comments on RGS thread. I'm not pitting one against another just comparing. I didn't particularly like the CR at 65c before the news could be digested by the market. Has stopped any short term run imo.